Teva Pharmaceuticals
TEVA
TEVA
506 hedge funds and large institutions have $11.5B invested in Teva Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 131 increasing their positions, 190 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
31% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 190
34% less call options, than puts
Call options by funds: $401M | Put options by funds: $612M
Holders
506
Holding in Top 10
10
Calls
$401M
Puts
$612M
Top Buyers
| 1 | +$579M | |
| 2 | +$392M | |
| 3 | +$370M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$308M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$66M |
Top Sellers
| 1 | -$156M | |
| 2 | -$109M | |
| 3 | -$85.5M | |
| 4 |
Millennium Management
New York
|
-$49.4M |
| 5 |
Morgan Stanley
New York
|
-$44.3M |